|Bid||20.64 x 1000|
|Ask||20.69 x 4000|
|Day's Range||17.78 - 21.25|
|52 Week Range||4.27 - 21.25|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.00|
Personalis, Inc. Launches NeXT Liquid Biopsy™, A High-Performance, Exome-Wide Liquid Biopsy Platform.
Personalis (PSNL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Personalis to Announce Second Quarter 2020 Financial Results on August 6, 2020